Maribel Mirabet graduated in Chemistry (Biochemistry specialty) in 1992 and obtained her PhD from the University of Barcelona in 1998. From 1999 to 2007 she worked as Postdoctoral Fellow and as Researcher at the Research Institute of the Hospital Vall d’Hebron in Barcelona (Spain), participating in projects investigating the mechanisms and consequences of platelet activation during acute myocardial infarction. From 2007 until 2010, she worked for the pharmaceutical industry at the Development Department of Ipsen Pharma (Sant Feliu de Llobregat, Spain), involved in the development of assays for immunogenicity studies. From 2010 until now, she is working as a Senior Scientist at the Assay Development Department of Biokit R&D (Lliçà d’Amunt, Spain), researching and developing chemiluminescent immunoassays. Her work at Biokit has been primarily focused on the development of a rapid and fully automated immunoassay to quantify ADAMTS13 activity in plasma.